Media Focus

Jun 29, 2021

Korea launches mRNA vaccine consortium

  • Their first goal is to secure the technology to produce a vaccine using synthetic messenger RNA, or mRNA. 
  • The Korean consortium aims to begin production of its COVID-19 vaccine next year to help the country overcome the ongoing pandemic. Its target is at least 100 million doses.
  • The companies say they will work to expand their manufacturing capacity to 1 billion doses by 2023.